Sangamo Therapeutics (SGMO) News Today $0.59 +0.01 (+2.29%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$0.58 -0.01 (-1.59%) As of 08/22/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SGMO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Short Interest Down 41.5% in JulyAugust 20, 2025 | marketbeat.comSangamo Therapeutics (NASDAQ:SGMO) Raised to "Hold" at Wall Street ZenAugust 19, 2025 | americanbankingnews.comQ3 EPS Forecast for Sangamo Therapeutics Boosted by AnalystAugust 17, 2025 | marketbeat.comWall Street Zen Upgrades Sangamo Therapeutics (NASDAQ:SGMO) to "Hold"August 17, 2025 | marketbeat.comAnalysts Issue Forecasts for SGMO Q4 EarningsAugust 16, 2025 | marketbeat.comSangamo Therapeutics, Inc. (NASDAQ:SGMO) Receives $4.50 Consensus PT from BrokeragesAugust 16, 2025 | americanbankingnews.comHC Wainwright Analysts Raise Earnings Estimates for SGMOAugust 16, 2025 | americanbankingnews.comSangamo Therapeutics, Inc. (NASDAQ:SGMO) Receives Average Rating of "Moderate Buy" from BrokeragesAugust 14, 2025 | marketbeat.comAnalysts Conflicted on These Healthcare Names: Sangamo Biosciences (SGMO), Pliant Therapeutics (PLRX) and Zimmer Biomet Holdings (ZBH)August 9, 2025 | theglobeandmail.comSangamo Therapeutics, Inc. (SGMO) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comSangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial ResultsAugust 7, 2025 | globenewswire.comGSA Capital Partners LLP Boosts Stock Position in Sangamo Therapeutics, Inc. (NASDAQ:SGMO)August 4, 2025 | marketbeat.comSangamo Therapeutics Announces Second Quarter 2025 Earnings CallJuly 31, 2025 | globenewswire.comSangamo Therapeutics (SGMO) Expected to Announce Quarterly Earnings on TuesdayJuly 30, 2025 | marketbeat.comSangamo Therapeutics Announces Positive Phase 1/2 STAAR Study Results for Fabry Gene TherapyJuly 25, 2025 | msn.comSangamo Therapeutics, Inc. (NASDAQ:SGMO) Given Consensus Recommendation of "Moderate Buy" by AnalystsJuly 19, 2025 | marketbeat.comH.C. Wainwright Reaffirms Buy Rating on Sangamo After Promising Gene Therapy DataJuly 3, 2025 | msn.comSGMO - Sangamo Therapeutics Inc Trailing Returns - MorningstarJuly 2, 2025 | morningstar.comMSangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease - MorningstarJune 25, 2025 | morningstar.comMSangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease - Business WireJune 25, 2025 | businesswire.comSangamo Therapeutics, Inc.: Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry DiseaseJune 24, 2025 | finanznachrichten.deSangamo rises after trial data for Fabry disease therapyJune 24, 2025 | msn.comSangamo Therapeutics (NASDAQ:SGMO) Given "Buy" Rating at HC WainwrightJune 24, 2025 | marketbeat.comSangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry DiseaseJune 24, 2025 | businesswire.comSangamo Therapeutics, Inc. (NASDAQ:SGMO) Given Average Rating of "Moderate Buy" by BrokeragesJune 24, 2025 | marketbeat.comTwo Sigma Investments LP Acquires 698,296 Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO)June 6, 2025 | marketbeat.comTwo Sigma Advisers LP Buys Shares of 707,555 Sangamo Therapeutics, Inc. (NASDAQ:SGMO)June 3, 2025 | marketbeat.comH.C. Wainwright Maintains Buy Rating on Sangamo Therapeutics (SGMO)May 31, 2025 | insidermonkey.comSangamo Therapeutics (NASDAQ:SGMO) Lowered to "Sell" Rating by Wall Street ZenMay 31, 2025 | marketbeat.comSangamo Therapeutics, Inc. (NASDAQ:SGMO) Given Average Recommendation of "Moderate Buy" by AnalystsMay 31, 2025 | marketbeat.comStockNews.com Initiates Coverage on Sangamo Therapeutics (NASDAQ:SGMO)May 24, 2025 | marketbeat.comSangamo Therapeutics (NASDAQ:SGMO) Now Covered by StockNews.comMay 24, 2025 | marketbeat.comPoint72 Asset Management L.P. Takes $2.32 Million Position in Sangamo Therapeutics, Inc. (NASDAQ:SGMO)May 23, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Decreases Holdings in Sangamo Therapeutics, Inc. (NASDAQ:SGMO)May 20, 2025 | marketbeat.comHC Wainwright Has Optimistic Outlook of SGMO Q3 EarningsMay 20, 2025 | marketbeat.comStock Traders Buy High Volume of Sangamo Therapeutics Call Options (NASDAQ:SGMO)May 15, 2025 | marketbeat.comSangamo Therapeutics (NASDAQ:SGMO) Posts Earnings ResultsMay 14, 2025 | marketbeat.comSangamo Therapeutics, Inc. (SGMO) Q1 2025 Earnings Call TranscriptMay 12, 2025 | seekingalpha.comSangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same DayMay 12, 2025 | finance.yahoo.comSangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial ResultsMay 12, 2025 | businesswire.comSangamo Therapeutics Announces Pricing of $23.0 Million Underwritten OfferingMay 12, 2025 | businesswire.comSangamo Therapeutics Q1 2025 Earnings PreviewMay 12, 2025 | msn.comSchonfeld Strategic Advisors LLC Purchases Shares of 1,709,615 Sangamo Therapeutics, Inc. (NASDAQ:SGMO)May 8, 2025 | marketbeat.comMarshall Wace LLP Has $344,000 Holdings in Sangamo Therapeutics, Inc. (NASDAQ:SGMO)May 7, 2025 | marketbeat.comSangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry DiseaseMay 7, 2025 | finance.yahoo.comSangamo Therapeutics Announces First Quarter 2025 Earnings CallMay 6, 2025 | businesswire.comSangamo Therapeutics, Inc. (NASDAQ:SGMO) Receives Average Recommendation of "Moderate Buy" from BrokeragesMay 6, 2025 | marketbeat.com740,000 Shares in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Acquired by Acuta Capital Partners LLCMay 4, 2025 | marketbeat.comBoothbay Fund Management LLC Takes Position in Sangamo Therapeutics, Inc. (NASDAQ:SGMO)May 3, 2025 | marketbeat.comSangamo Therapeutics (SGMO) Expected to Announce Quarterly Earnings on ThursdayMay 3, 2025 | marketbeat.com Get Sangamo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SGMO and its competitors with MarketBeat's FREE daily newsletter. Email Address SGMO Media Mentions By Week SGMO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGMO News Sentiment▼0.910.71▲Average Medical News Sentiment SGMO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGMO Articles This Week▼23▲SGMO Articles Average Week Get Sangamo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SGMO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MYGN News VSTM News EBS News LXRX News XOMA News CDXS News CBIO News VNDA News IRWD News AGEN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGMO) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sangamo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sangamo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access